focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 250.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 50.00 (20.00%)
Open: 275.00
High: 275.00
Low: 275.00
Prev. Close: 275.00
HSM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

12 Nov 2020 07:00

RNS Number : 0488F
Heath(Samuel) & Sons PLC
12 November 2020
 

SAMUEL HEATH & SONS plc

("the Company")

 

INTERIM REPORT

 

Half year ended 30 September 2020

 

CHAIRMAN'S STATEMENT

 

 

This has been the most extraordinary half year in my rather lengthy business career. Regrettably there is still not yet a clear outcome by any means.

 

Our trading performance for the six months until September 30th was quite a lot better than feared but still only produced a small profit of £6k before exceptional items (2019: £363k), on sales of £4.850m (2019: £6.920m). As I mentioned in my annual report, without any doubt this was greatly aided by the Government's furlough scheme. This was imaginative and effective. It helped us on all sides of the business, but particularly on the sales side. However, as it was coming to an end, we had to make some difficult decisions to protect the future of the Company. This resulted in considerable redundancy payments, shown in the accounts as exceptional. This brought our total half year results to a loss of £224k before taxation (2019: profit £363k).

 

You cannot run a business like ours successfully for long without a considerable sales team, focussed marketing activities and continual research and development. We have therefore brought these back into play for the second half of the year. This is clearly not without risk.

 

There are differing views on the next six months. We have the U.S. election which could affect a manufacturer at the luxury end of the market, the unknown outcome of the talks with the EU, and, by far the worst of all, the return in volume of the Coronavirus. Anybody offering a forecast in these circumstances would be extremely unwise.

 

This leaves the question of the dividend. Apart from the ethical question of whether we should pay out dividends when in receipt of Government money, notwithstanding the millions we have paid over the years in taxes, there is more importantly the possible cash requirements of the Company over the next six months. We have therefore decided not to pay an interim dividend but hope to return to normality next year.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Sam Heath

Chairman

11 November 2020

 

For further information, please contact:

Samuel Heath & Sons Plc

Simon Latham, Company Secretary 0121 766 4200

 

Cairn Financial Advisers LLP

James Caithie / Jo Turner 020 7213 0880

 

Unaudited Interim Financial Report

For the Half Year ended 30 September 2020

 

CONSOLIDATED INCOME STATEMENT

 

 

 

 

 

 

Half year

 

Half year

 

Year

 

ended 30

 

ended 30

 

ended 31

 

September

 

September

 

March

 

2020

 

2019

 

2020

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

Revenue

4,850

 

6,920

 

13,887

 

 

 

 

 

 

Cost of sales

(3,062)

 

(3,598)

 

(6,798)

 

 

 

 

 

 

Gross profit

1,788

 

3,322

 

7,089

 

 

 

 

 

 

Selling and distribution costs

(1,344)

 

(1,776)

 

(3,543)

Administrative expenses

(940)

 

(1,067)

 

(2,012)

Other operating income - grant (note 6)

596

 

-

 

-

 

 

 

 

 

 

Operating profit

100

 

479

 

1,534

 

 

 

 

 

 

Finance income

14

 

 9

 

25

Finance cost

(108)

 

(125)

 

(191)

 

 

 

 

 

 

 

 

 

 

 

 

Profit before taxation and exceptional items

 

6

 

363

 

1,368

 

 

 

 

 

 

Exceptional item (note 5)

(230)

 

-

 

-

 

 

 

 

 

 

(Loss)/profit before taxation

(224)

 

363

 

1,368

 

 

 

 

 

 

Taxation

43

 

(69)

 

(299)

 

 

 

 

 

 

(Loss)/profit for the period

(181)

 

294

 

1,069

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted (loss)/earnings per ordinary share (note 4)

(7.1p)

 

11.6p

 

42.2p

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

 

 

 

 

Half year ended 30 September

 

Half year ended 30 September

 

Year ended 31 March

 

 

2020

 

2019

 

2020

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

(Loss)/profit for the period

(181) 

 

294

 

1,069

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Items that will not be reclassified to profit or loss:

 

 

 

 

 

Actuarial gain/(loss) on defined benefit pension scheme

(1,239)

 

 204

 

291

Deferred tax on actuarial loss/(gain)

218

 

(34)

 

(55)

Deferred tax rate change

-

 

-

 

125

Revaluation of property, plant and equipment

-

 

-

 

182

Deferred taxation on revaluation of assets

-

 

-

 

(23)

 

 

 

 

 

 

 

(1,021)

 

170

 

520

 

 

 

 

 

 

Total comprehensive income for the period

(1,202)

 

464

 

1,589

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

At 30 September

 

 At 30 September

 

At 31 March

 

 

2020

 

2019

 

2020

 

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

Non-current assets

 

 

 

 

 

Intangible assets

135

 

74

 

151

Property, plant and equipment

3,541

 

3,519

 

3,635

Deferred tax assets

1,103

 

972

 

887

 

 

 

 

 

 

 

4,779

 

4,565

 

4,673

 

 

 

 

 

 

Current assets

 

 

 

 

 

Inventories

3,869

 

3,883

 

4,230

Trade and other receivables

1,689

 

2,216

 

2,370

Cash and cash equivalents

3,424

 

3,100

 

3,016

 

8,982

 

9,199

 

9,616

 

 

 

 

 

 

Total assets

13,761

 

13,764

 

14,289

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Trade and other payables

(1,772)

 

(1,665)

 

(1,868)

Right of use lease liabilities

(53)

 

(57)

 

(58)

Current tax payable

(36)

 

(239)

 

(79)

 

(1,861)

 

(1,961)

 

(2,005)

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

Right of use lease liabilities

(26)

 

(75)

 

(46)

Retirement benefit scheme

(7,413)

 

(7,050)

 

(6,575)

 

(7,439)

 

(7,125)

 

(6,621)

 

 

 

 

 

 

Total liabilities

(9,300)

 

(9,086)

 

(8,626)

 

 

 

 

 

 

Net assets

4,461

 

4,678

 

5,663

 

 

 

 

 

 

Equity

 

 

 

 

 

Called up share capital

254

 

254

 

254

Capital redemption reserve

109

 

109

 

109

Revaluation reserve

Retained earnings

1,308

2,790

 

1,224

3,091

 

1,349

3,951

 

 

 

 

 

 

Equity shareholders' funds

4,461

 

4,678

 

5,663

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

       

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

Share capital

Capital redemption reserve

Revaluation reserve

Retained earnings

Total equity

 

£000

£000

£000

£000

£000

 

 

 

 

 

 

Balance at 31 March 2019

254

109

1,277

2,748

4,388

 

Total transactions with owners

 

 

 

 

 

Equity dividends paid

-

-

-

(174)

 (174)

 

 

 

 

 

 

Profit for the period

-

-

-

294

294

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(53)

170

 

53

170

 

-

Total comprehensive income for the period

-

-

(53)

517

464

 

 

 

 

 

 

Balance at 30 September 2019

254

109

1,224

3,091

4,678

 

Total transactions with owners

 

 

 

 

 

Equity dividends paid

-

-

-

(140)

(140)

 

 

 

 

 

 

Profit for the period

-

-

-

775

775

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

159

 

(34)

191

 

34

350

 

-

Total comprehensive income for the period

-

-

125

1,000

1,125

 

 

 

 

 

 

Balance at 31 March 2020

254

109

1,349

3,951

5,663

 

 

 

 

 

 

Total transactions with owners

Equity dividends paid

-

-

-

-

-

 

 

 

 

 

 

Loss for the period

-

-

-

(181)

(181)

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(41)

(1,021)

 

41

(1,021)

 

-

Total comprehensive income for the period

-

-

(41)

(1,161)

(1,202)

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 September 2020

254

109

1,308

2,790

4,461

 

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

 

 

Half year ended 30 September

 

Half year ended 30 September

 

Year ended 31 March

 

2020

 

2019

 

2020

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

Cash flow from operating activities

 

 

 

 

 

 

 

 

 

 

 

(Loss)/profit for the period before taxation

(224)

 

363

 

1,368

 

 

 

 

 

 

Adjustments for:

 

 

 

 

 

Depreciation

155

 

192

 

405

Amortisation

16

 

8

 

16

Loss/(profit) on disposal of property, plant and equipment

-

 

3

 

(3)

Net finance cost/(income)

(14)

 

7

 

(25)

Defined benefit pension scheme expenses

98

 

137

 

228

Contributions to defined benefit pension scheme

(500)

 

(266)

 

(783)

 

 

 

 

 

 

Operating cash flow before movements in working capital

(469)

 

444

 

1,206

 

 

 

 

 

 

Changes in working capital:

 

 

 

 

 

Decrease/(increase) in inventories

361

 

 106

 

(241)

Decrease/(increase) in trade and other receivables

658

 

46

 

(84)

(Decrease)/increase in trade and other payables

(65)

 

23

 

79

 

 

 

 

 

 

Cash generated from operations

485

 

619

 

960

 

 

 

 

 

 

Taxation paid

-

 

-

 

(180)

 

 

 

 

 

 

Net cash from operating activities

485

 

619

 

780

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

 

Payments to acquire property, plant and equipment

(61)

 

(510)

 

(502)

Proceeds from the sale of property, plant and equipment

-

 

19

 

14

Payments to acquire intangible assets

-

 

-

 

(85)

Net finance income

14

 

(5)

 

25

 

 

 

 

 

 

 

(47)

 

(496)

 

(548)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

 

Payment for right of use assets

(30)

 

(2)

 

(55)

Dividends paid

-

 

(174)

 

(314)

 

 

 

 

 

 

 

(30)

 

(176)

 

(369)

 

 

 

 

 

 

 

 

 

 

 

 

Net increase in cash and cash equivalents

408

 

(53)

 

(137) 

Cash and cash equivalents at beginning of period

3,016

 

3,153

 

3,153

 

 

 

 

 

 

Cash and cash equivalents at end of period

3,424

 

3,100

 

3,016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTES TO THE INTERIM FINANCIAL REPORT

 

 

1. BASIS OF PREPARATION OF INTERIM REPORT

As permitted, IAS34 'Interim Financial Reporting' has not been applied in this interim report. The information for the period ended 30 September 2020 is not audited and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The statutory accounts for the year ended 31 March 2020 were given an unqualified audit report and did not contain statements under section 498(2) or 498(3) of the Companies Act 2006. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The interim accounts for the half year ended 30 September 2019 were also unaudited.

2. ACCOUNTING POLICIES

Basis of accounting

The report has been prepared on a going concern basis in accordance with International Financial Reporting Standards and interpretations issued by the International Financial Reporting Interpretations Committee as adopted by the European Union.

 

The group has not availed itself of early adoption options in standards and interpretations.

 

The principal accounting policies adopted are as set out in the Annual Report for the year ended 31 March 2020. The valuation of inventories is considered to be the main area in terms of significant accounting estimates and judgements.

The retirement benefit scheme liability recognised in these interim accounts reflects the estimated change in the deficit at 30 September 2020 from the movements in discount rates and inflation during the six months.

3. DIVIDENDS

 

No Interim dividend is proposed (paid 20 March 2020: 5.5p).

4. (LOSS)/EARNINGS PER SHARE 

The basic and diluted (loss)/earnings per share are calculated by dividing the relevant loss after taxation of £181,000 (30 September 2019: profit £294,000) by the average number of ordinary shares in issue during the period being 2,534,322 (2019: 2,534,322). The number of shares used in the calculation is the same for both basic and diluted earnings.

5. EXCEPTIONAL ITEM

The exceptional item for the 6 months to 30 September 2020 relates to restructuring costs within the business.

6. OTHER OPERATING INCOME - GRANT FUNDING

Income has been received from government grants providing support during the Coronavirus pandemic:

JRS £571,000

Borough Hammersmith & Fulham £ 25,000

 

Income has been accounted for under the accruals method.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BIBDBLDBDGGB
Date   Source Headline
28th Oct 20155:20 pmRNSNotice of Results
15th Jul 20157:00 amRNSFinal Results
12th Jun 20151:04 pmRNSNotice of Results
12th Nov 20147:00 amRNSInterim Report
3rd Nov 20141:41 pmRNSNotice of Results
1st Sep 20149:38 amRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
4th Jul 20142:25 pmRNSNotice of Results
19th Dec 20139:42 amRNSHolding(s) in Company
19th Dec 20139:40 amRNSHolding(s) in Company
6th Nov 20137:00 amRNSInterim Report
31st Oct 201311:18 amRNSNotice of Results
17th Jul 20137:00 amRNSPreliminary Results
11th Jul 20132:56 pmRNSNotice of Results
15th Jan 201312:09 pmRNSDirector/PDMR Shareholding
20th Nov 20127:00 amRNSHalf Yearly Report
9th Nov 20121:30 pmRNSNotice of Results
19th Sep 20121:48 pmRNSDirector/PDMR Shareholding
12th Sep 20121:44 pmRNSHolding(s) in Company
12th Sep 20129:01 amRNSDirector/PDMR Shareholding
20th Jul 201212:45 pmRNSHolding(s) in Company
12th Jul 20127:00 amRNSFinal Results
4th Jul 20128:48 amRNSNotice of Results
3rd Feb 20124:52 pmRNSDirector/PDMR Shareholding
22nd Nov 20117:00 amRNSHalf Yearly Report
15th Nov 201110:34 amRNSAppointment of Director
9th Nov 20114:37 pmRNSNotice of Results
7th Jul 20117:00 amRNSFinal Results
17th Jun 20114:13 pmRNSNotice of Results
4th Jan 20117:00 amRNSChange of Adviser
23rd Nov 20107:00 amRNSHalf Yearly Report
12th Nov 20103:17 pmRNSNotice of Results
3rd Aug 201011:11 amRNSDirector/PDMR Shareholding
2nd Aug 20102:50 pmRNSHolding(s) in Company
8th Jul 20107:00 amRNSDirectorate Change
8th Jul 20107:00 amRNSFinal Results
2nd Jul 20102:02 pmRNSNotice of Results
1st Apr 20103:37 pmRNSHolding(s) in Company
2nd Dec 20091:59 pmRNSRe Interim Report
24th Nov 20097:00 amRNSHalf Yearly Report
16th Nov 200910:24 amRNSNotice of Results
30th Sep 20092:47 pmRNSAnnual Report and Accounts
9th Jul 20097:00 amRNSFinal Results
3rd Jul 20091:27 pmRNSNotice of Results
26th Jan 200911:47 amRNSHolding(s) in Company
8th Dec 20084:40 pmRNSDirectorate Change
4th Dec 20087:00 amRNSInterim Results
20th Nov 200812:12 pmRNSNotice of Results
19th Sep 20081:27 pmRNSAnnual Report and Accounts
4th Jul 200811:17 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.